• Explore /
  • Poster
  • / Extrachromosomal DNA (ecDNA) carrying amplified oncogenes as a biomarker for insensitivity to checkpoint inhibitor treatment in gastric cancer patients.

Extrachromosomal DNA (ecDNA) carrying amplified oncogenes as a biomarker for insensitivity to checkpoint inhibitor treatment in gastric cancer patients.

Abstract Video & Slides Poster

Authors

null

Jason H. Christiansen

Boundless Bio, Inc., La Jolla, CA

Jason H. Christiansen , Nam-phuong Nguyen , Roel Verhaak , Hoon Kim , Vineet Bafna , Paul Mischel , Christian Hassig

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Tissue-Based Biomarkers

Citation

J Clin Oncol 38: 2020 (suppl; abstr 3123)

DOI

10.1200/JCO.2020.38.15_suppl.3123

Abstract #

3123

Poster Bd #

187

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Microsatellite instability (MSI) in patients with gastric cancer (GC) and correlation with PD-L1 expression.

Microsatellite instability (MSI) in patients with gastric cancer (GC) and correlation with PD-L1 expression.

First Author: Henian Sun

First Author: Rebecca A Sager

First Author: Maroun Bou Zerdan

First Author: Takayuki Yoshino